9/22/2022
`
`Benjamin Morris Greenberg, MD, MHS, FAAN, FANA, CRND
`Professor
`Director, Perot Foundation Neurosciences Translational Research Center
`Director, Transverse Myelitis and Neuromyelitis Optica Program
`Co-Director, Pediatric CONQUER Program
`Cain Denius Scholar in Mobility Disorders
`Distinguished Teaching Professor
`Vice Chair, Clinical and Translational Research
`Department of Neurology
`Department of Pediatrics UT
`Southwestern Medical Center
`
`Personal:
`
`Place of Birth:
`Citizenship:
`
`Houston, Texas, USA
`United States
`
`Address:
`
`5323 Harry Hines Blvd
`Mail Code 8806
`Dallas, Texas 75390-8806
`
`Telephone:
`Fax:
`Email:
`
`(214) 645-0555
`(214) 645-0556
`Benjamin.Greenberg@UTSouthwestern.edu
`
`Education and Training:
`Undergraduate:
`1997
`Johns Hopkins University (Baltimore, MD)
`
`B.A. (History of Medicine)
`
`Graduate:
`1997
`Johns Hopkins School of Public Health (Baltimore, MD) M.H.S. (Microbiology and
`Immunology)
`
`Medical:
`2001 Baylor College of Medicine (Houston, TX)
`
`M.D.
`
`Internship:
`7/01 – 6/02
`
`Residency:
`7/02-6/04
`
`Rush-Presbyterian-St. Lukes Hospital (Chicago, IL) Internal Medicine
`
`Johns Hopkins Hospital (Baltimore, MD)
`
`Neurology
`
`Chief Resident:
`7/04-6/05
`Johns Hopkins Hospital (Baltimore, MD)
`
`Neurology
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 1 of 42
`
`

`

`9/22/2022
`
`Post Doctoral Fellow:
`7/05-6/07
`Johns Hopkins School of Public Health Microbiology and Immunology
`Board Certification and Licensure:
`
`2006
`2016
`
`2004-2010
`2009-present
`2015 – present
`
`Diplomate, American Board of Psychiatry and Neurology
`Recertification, Diplomate, American Board of Psychiatry and
`Neurology
`Maryland State License, D0062299
`Texas State License, N2095
`Certification in Rare Neuroimmunologic Disorders
`
`Major Honors and Awards:
`
`1997 City of Baltimore Mayor’s Citation
`2001 Alpha Omega Alpha Society, Baylor College of Medicine
`2001 Hero of the Heart (Rush Hospital award for compassionate care)
`Intern of the Year Award, Rush Internal Medicine
`2002
`2004
`Service Award from Maryland Multiple Sclerosis Society
`2005 American Academy of Neurology Resident Travel Scholarship
`2005
`Johns Hopkins Guy McKhann Resident Teaching Award
`2008
`Johns Hopkins Frank Ford Department of Neurology Teaching Award
`2009 ACP Physician of Distinction Award
`2010 UT Southwestern First Year Medical School Teaching Award
`2010 UT Southwestern Department of Neurology Trephined Cranium Teaching Award
`2011 UT Southwestern First Year Medical School Teaching Award
`Fred Baskin Young Investigator Research Award
`2011
`2012 UT Southwestern First Year Medical School Teaching Award
`2013 UT Southwestern First Year Medical School Teaching Award
`2014 UT Southwestern First Year Medical School Teaching Award
`2014 UT Southwestern First Year Medical School Best Course Award
`(Neurosciences Course Co-Director)
`2015 UT Southwestern First Year Medical School Teaching Award
`2015 UT Southwestern First Year Medical School Best Course Award
`(Neurosciences Course Co-Director)
`2015 University of Texas Board of Regents Teaching Award
`2016 University of Texas Southwestern Academy of Teachers (SWAT)
`2016 D Magazine, Best Doctors in Dallas
`2016 UT Southwestern Second Year Medical School Teaching Award
`2017 D Magazine, Best Doctors in Dallas
`2017 UT Southwestern Second Year Medical School Teaching Award
`2018 D Magazine, Best Doctors in Dallas
`2019 D Magazine, Best Doctors in Dallas
`2019 UT Southwestern Second Year Medical School Teaching Award
`2020 D Magazine, Best Doctors in Dallas
`2021 D Magazine, Best Doctors in Dallas
`2021 UT Southwestern Second Year Medical School Teaching Award
`2022 D Magazine, Best Doctors in Dallas
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 2 of 42
`
`

`

`
`
`
`
`University of Texas Southwestern, Department of Neurology Associate
`
`University of Texas Southwestern, Department of Pediatrics Associate
`
`University of Texas Southwestern, Department of Neurology Professor
`University of Texas Southwestern, Department of Pediatrics Professor
`
`Johns Hopkins School of Medicine, Department of Neurology
`
`Johns Hopkins School of Medicine, Department of Neurology
`
`University of Texas Southwestern, Department of Neurology Assistant
`
`
`
`University of Texas Southwestern, Department of Pediatrics Assistant
`
`9/22/2022
`
`2022 UT Southwestern Second Year Medical School Teaching Award
`
`
`
`
`
`Academic Appointments:
`
`
`2005-2006
`Clinical Instructor
`2006-2008
`
`Assistant Professor
`2009-2013
`
`Professor
`2012-2013
`Professor
`2013-2019
`Professor
`2013-2019
`Professor
`2019-present
`2019-present
`
`
`
`Hospital Appointments
`
`Johns Hopkins Bayview Hospital
`2005-2008
`Johns Hopkins Hospital
`2005-2008
`2009-present Parkland Hospital
`2009-present Zale-Lipshy Hospital
`2009-2014
`St. Paul University Hospital
`2009-present Childrens Hospital
`2015-present Children’s Medical Center Plano
`2014-present Clements University Hospital
`
`
`Administrative Responsibilities, Committees and Service
`
`
`Department
`Residency Selection
`Johns Hopkins Department of Neurology
`2005-2008
`Fellowship Director
`Johns Hopkins Department of Neurology
`2007-2008
`Committee Member
`UTSWDepartment of Neurology Med. Ed.
`2010-2014
`Vice-Chair (Interim)
`Ambulatory Affairs
`2016-2017
`Vice-Chair
`2016-present Clinical and Translational Research
`Fellowship Director
`2016-present Autoimmune Neurology
`Fellowship Director
`2017-present Multiple Sclerosis
`Section Head (Interim)
`2017-2022
`Neuroimmunology
`Vice-Chair
`2017-2021
`Strategic Initiatives
`2020-2022
`Behavioral Neurology Section Head Search Comm. Committee Member
`
`Neurology Attending
`Neurology Attending
`Neurology Attending
`Neurology Attending
`Neurology Attending
`Neurology Attending
`Neurology Attending
`Neurology Attending
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 3 of 42
`
`

`

`9/22/2022
`
`Neuroimmunology Section Head Search Comm. Committee Member
`2020-2021
`2020-present Neurology Research Review Board
`Committee Chair
`2021-present Sleep Section Head Search Comm.
`Committee Chair
`
`
`Hospital
`Physician Order Entry Committee
`
`
`Johns Hopkins
`2005-2007
`Founder, Director
`2009-present Children’s Health CONQUER Clinic
`
`
`
`Member
`2014-2018 University Hospital Lab Advisory Comm.
`2017-2018 Moncrief Medical Center Site Governance Committee
`Member
`
`
`
`School of Medicine
`2013-present Neurosciences Translational Research Center
`2013-2017 Neurosciences Pre-Clinical Course
`
`
`
`CTM Grant Review Committee
`2017
`
`
`
`2018
`CTM Grant Review Committee
`
`
`
`2019
`CCRAC Grant Review Committee
`
`
`2019-present UTSW Biorepository Oversight Committee
`
`
`UTSW Clinic Strategic Planning Committee
`2019
`
`2020
`Clinical Research Advisory Committee
`
`
`2020-present Institutional Review Board
`
`
`
`
`2021-present Continuing Education Advisory Committee
`
`
`
`
`
`CLINICAL ACTIVITIES
`
`
`2006-2008 Co-Director, Johns Hopkins Transverse Myelitis Center
`
`
`Expanded clinical and translational research programs of the Johns Hopkins Transverse
`Myelitis Center in partnership with Dr. Douglas Kerr. This was the first and only program
`dedicated to TM clinical care and research.
`
`
`2007-2008 Director, Johns Hopkins Encephalitis Center
`
`
`Founded the first clinical and translational research program dedicated to encephalitis at
`Johns Hopkins Hospital. This program focused on development of treatment and diagnosis
`algorithms for acute encephalitis patients.
`
`2009-present Director,
`
`Director
`Co-Director
`Member
`Member
`Member
`Member
`Member
`Member
`Member
`Member
`
`University of Texas Southwestern Transverse
`Myelitis and Neuromyelitis Optica Program
`Upon recruitment to the University of Texas Southwestern Department of Neurology, Dr.
`Greenberg formalized the clinical and translational research programs focused on patients
`with TM and NMO. Patients with these rare disorders had previously received their care as
`part of the MS program at UT Southwestern. With the establishment of this program, patients
`from around the world travel to UT for clinical care and to take part in research endeavors.
`
`2009-present Founder, Co-Director,
`
`
`
`
`
`University of Texas Southwestern Pediatric
`CONQUER Program
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 4 of 42
`
`

`

`9/22/2022
`
`
`In 2009 the pediatric demyelinating disease program was founded by Dr. Greenberg. Located
`at Childrens Hospital, this program cares for pediatric patients with multiple sclerosis,
`transverse myelitis, neuromyelitis optica, optic neuritis, acute disseminated encephalomyelitis
`and other immune mediated diseases of the CNS. The outpatient clinic provides
`multidisciplinary care to patients and families from around the country. Dr. Greenberg has
`coordinated a team of neurologists, neuropsychologists, physiatrists, physical therapists,
`occupational therapists, urologists, social workers, nurses and school liaisons.
`
`2009-2013
`
`Deputy-Director
`
`University of Texas Southwestern Multiple
`Sclerosis Program
`
`
`
`Partnering with Dr. Elliot Frohman in 2009, Dr. Greenberg became the Deputy Director of
`the Multiple Sclerosis Program. Assisting in the administrative duties of the MS center, Dr.
`Greenberg worked to streamline the referral and appointment process, and expand data
`collection for clinical research endeavors.
`
`
`2017-2022
`
`Interim-Director
`
`University of Texas Southwestern Multiple
`Sclerosis/Neuroimmunology Program
`
`
`
`Dr. Greenberg became the Interim Director of the Multiple Sclerosis Program after the
`departure of Dr. Frohman in 2017. Leading in the administrative, clinical, research and
`education duties of the MS center, Dr. Greenberg has worked to streamline the referral and
`appointment process, expand data collection for clinical research endeavors, oversee the
`fellowship and improve the quality of care.
`
`
`
`
`EDUCATIONAL ACTIVITIES and RESPONSIBILITIES
`
`Current and Past Teaching Responsibilities
`
`2005-2006 Anatomy and Physiology, Johns Hopkins School of Public Health Lecturer
`2006-2008 Neurology Core Curriculum, Johns Hopkins School of Medicine Lecturer
`2010-present Neurosciences, University of Texas Southwestern Lecturer
`2010-present Neurosciences, University of Texas Southwestern Lab Instructor
`2011-present Neurosciences, School of Allied Health,
`Lecturer
`University of Texas Southwestern
`2013-2017 Neurosciences, University of Texas Southwestern Co-Director
`
`
`CME Courses:
`Multiple Sclerosis: Update 2006
`Course Director and Speaker
`New Insights Into MS Neurodegeneration and Neuroprotection
`Program Director and Speaker
`Rare Neuroimmunologic Diseases Symposium
`Speaker
`
`February 25, 2006
`
`March 17, 2007
`
`April 27, 2007
`
`
`
`
`
`
`
`
`
`
`
`
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 5 of 42
`
`

`

`May 30, 2007
`
`
`
`July 25, 2007
`
`September 8, 2007
`
`April 11, 2010
`
`April 12, 2010
`
`
`
`
`
`
`
`
`9/22/2022
`
`
`Mastering MS: Practical Strategies for Challenging Cases
`Chairperson and Speaker
`New Approaches to Modifying Neurological Disease
`Speaker
`A Multisite Think Tank on the Challenges of Multiple Sclerosis
`Chairperson and Speaker
`A Multisite Think Tank on the Challenges of Multiple Sclerosis September 29, 2007
`Chairperson and Speaker
`Current Issues and Ongoing Challenges in MS: Neurodegeneration and Neuroprotection,
`Chairperson and Speaker
`
`
`
`
`
`April 26, 2008
`Current Issues and Ongoing Challenges in MS: Neurodegeneration and Neuroprotection,
`Chairperson and Speaker
`
`
`
`
`
`September 27, 2008
`Current Issues and Ongoing Challenges in MS: Neurodegeneration and Neuroprotection,
`Speaker
`
`
`
`
`
`
`
`March 7, 2009
`Emerging Therapeutics, AAN Multiple Sclerosis Update
`
`May 1, 2009
`Speaker
`Emerging Therapeutics, AAN Multiple Sclerosis Update
`Speaker
`Neuroflash: Multiple Sclerosis Diagnostic Mimics, AAN
`Speaker
`Neuromyelitis Optica Update: Evaluating Acute and Subacute Myelopathies
`Speaker
`
`
`
`
`
`
`
`April 17, 2010
`Rare Neuroimmunologic Disorders Symposium
`
`
`September 24, 2010
`Director, Speaker
`Neuromyelitis Optica Update: Evaluating Acute and Subacute Myelopathies
`Speaker
`
`
`
`
`
`
`
`April 11, 2011
`Emerging Therapeutics, AAN Multiple Sclerosis Update
`April 15, 2011 Speaker
`CNS Infections, Tx Academy of Physician Assistants Conference February 24, 2012
`Speaker
`Transverse Myelitis: Approach to Acute Care, CMSC
`ECTRIMS: Highlights of Presentations from ECTRIMS
`Speaker
`MS and Its Masquerades: Making the Diagnosis, Considering the Differential Diagnosis,
`American Academy of Neurology,
`
`
`
`March 17, 2013
`Speaker
`Addressing the Challenges of MS: An Interactive Workshop Series April 20, 2013
`Speaker
`Assessing the Need to Switch Therapy in Multiple Sclerosis
`Speaker
`Neuropsychology in Multiple Sclerosis, CMSC
`Course Chair and Presenter
`Patient Centered CME
`Course Director and Presenter
`MS and Its Masquerades: Making the Diagnosis, Considering the Differential Diagnosis,
`American Academy of Neurology,
`
`
`
`May 3, 2014
`Speaker
`Medical Myelopathies, American Academy of Neurology,
`TAPA Annual Conference, CNS Infections
`
`
`
`May 31, 2012 Speaker
`November 12, 2012
`
`May 30, 2013
`
`
`
`
`
`May 31, 2013
`
`Summer 2013
`
`May 3, 2014 Speaker
`February 22, 2015
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 6 of 42
`
`

`

`
`
`
`
`
`
`
`
`February 24, 2015
`
`April 11, 2015
`
`9/22/2022
`
`
`Speaker
`Childrens Multidisciplinary Case Conference
`Speaker
`Multiple Sclerosis Diagnosis and Treatment
`Co-Director and Speaker, Dallas, Texas
`MS and Its Masquerades: Making the Diagnosis, Considering the Differential Diagnosis,
`American Academy of Neurology,
`
`
`
`April 19, 2015
`Speaker
`Medical Myelopathies, American Academy of Neurology,
`Speaker
`MS Think Tank Director,
`Speaker
`Advances in Neurology, Houston Methodist Neurosciences
`Speaker
`ECTRIMS: Highlights of Presentations from ECTRIMS Speaker November 16, 2015
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Myelopathies I, American Academy of Neurology
`Director, Speaker
`Myelopathies II, American Academy of Neurology
`Director
`Multiple Sclerosis Update,
`Speaker, Dallas, Texas
`
`Successful APP-physician Team Models, AAN
`
`Moderator, Panelist
`
`
`
`
`MS: Ask the Expert, American Academy of Neurology
`Speaker
`Myelopathies I, American Academy of Neurology
`Director, Speaker
`Myelopathies II, American Academy of Neurology
`Director
`Think Tank: Management of Immunotherapies in MS
`Director
`Neurosciences for School Based Therapists Speaker,
`Organizer
`ECTRIMS: Highlights of Presentations from ECTRIMS
`Speaker
`Integrating APPs into a Neurology Practice, AAN Speaker
`
`April 21, 2015
`
`June 27, 2015
`
`September 12, 2015
`
`April 25, 2106
`
`April 25, 2016
`
`November 29, 2016
`
`April 24, 2017
`
`April 25, 2017
`
`April 25, 2107
`
`April 25, 2017
`
`September 23, 2017
`
` November 10, 2017
`
`
`
`
`
`Acute Flaccid Myelitis, Academy of Neurology
`Speaker
`Myelopathies I, American Academy of Neurology
`Director, Speaker
`Myelopathies II, American Academy of Neurology
`Director, Speaker
`Myelopathies, American Academy of Neurology
`Director, Speaker
`Acute Flaccid Myelits, Hoag Neurosciences CME Course
`Speaker
`
`
`
`
`
`
`
`
`
`
`
`January 16, 2018
`
`April 24, 2018
`
`April 25, 2018
`
`April 26, 2108
`
`April 26, 2018
`
`May 6, 2019
`
`November 9, 2019
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 7 of 42
`
`

`

`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`March 2022
`
`June 2022
`
`June 2022
`
`July 2022
`
`9/22/2022
`
`
`12th Annual Year in Review: Advances in the Treatment of Multiple Sclerosis”
`Speaker
`
`
`
`
`
`
`
`November 9. 2020
`An Update on COVID-19 and MS: Disease-Modifying Therapies and COVID Vaccines
`Moderator, Speaker
`
`
`
`
`
`
`March 29, 2021
`Evolving Treatment Paradigms in the Management of Multiple Sclerosis: How New and
`Emerging Therapies are Changing the Treatment Landscape
`April 22, 2021
`Managed Care Forum, Speaker
`Updates on NMO spectrum disorders
`
`
`July 23, 2021
`
`
`
`Texas Neurology Society, Speaker
`
`The Role of Brain Penetrant BTK Inhibitors to Improve Outcomes in Patients with Multiple
`Sclerosis
`
`
`
`
`
`
`
`
`CMSC, Speaker
`
`
`
`
`
`
`October 2021
`Effective Patient Education in MS Therapy Selection: Applying Clinical Understanding to
`Support Shared Decision Making
`
`UT Southwestern CME, Speaker
`BTK inhibitors: The Science of New Drugs
`CMSC, Course Director, Speaker
`
`MS Treatments on the Horizon
`
`CMSC, Speaker
`
`
`Diagnostic Criteria in Transverse Myelitis
`AAN Summer Conference, Speaker
`
`
`
`
`Teleconferences/Podcasts:
`Research Update for National Multiple Sclerosis Society, March 18, 2006 Research Update
`for National Multiple Sclerosis Society, March 11, 2008
`Understanding Repair and Recovery After Non-Traumatic Spinal Cord Injury,
`Transverse Myelitis Association
`September 9, 2013
`Children with Rare Neuro-Immune Disorders: Understanding Medical, Educational and
`Social Considerations
`December 13, 2013
`Transverse Myelitis Association
`Managing Bladder, Bowel and Sexual Function After Non-Traumatic Spinal Cord Injury,
`Transverse Myelitis Association,
`February 17, 2014
`Understanding Autoimmunity and Rare Neuro-Immune Disorders,
`Transverse Myelitis Association,
`March 25, 2014
`Understanding Pediatric NMO, ADEM and TM,
`Transverse Myelitis Association,
`Diagnosing TM, NMO and ADEM,
`Transverse Myelitis Association
`Comprehensive Management of Neuropathic Pain,
`Transverse Myelitis Association,
`Learning About Acute Disseminated Encephalomyelitis,
`May 19, 2016
`Transverse Myelitis Association,
`Understanding Types of Research in ADEM, NMOSD, and TM, including AFM,
`Transverse Myelitis Association,
`September 30, 2016
`Understanding Acute Flaccid Myelitis,
`Transverse Myelitis Association,
`
`July 18, 2014
`
`January 27, 2016
`
`February 24, 2016
`
`November, 11, 2016
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 8 of 42
`
`

`

`9/22/2022
`
`
`Building a Multidisciplinary Team for Complex Care After a Diagnosis of ADEM, NMOSD,
`ON, and TM (Including AFM),
`January 19, 2017
`Transverse Myelitis Association,
`How to get the most out of your appointments: Physician and patient perspectives
`Transverse Myelitis Association,
`September 25, 2017
`MOG Antibody Mediated Disease
`Transverse Myelitis Association,
`COVID and Multiple Sclerosis
`Update on Diagnostic Criteria for Transverse Myelitis
`Siegal Rare Neuroimmune Association
`
`
`
`
`Meetings
`Genetic Environment Interactions in Multiple Sclerosis
`Chair and Organizer; Cold Spring Harbor Laboratories, Banbury Center
`Multiple Sclerosis Clinical Trials Scientific Platform Session, Co-Chair
`American Academy of Neurology
`Rare Neuroimmunologic Disorders Symposium
`26th, 2010 Director, Speaker, Dallas, Texas
`Multiple Sclerosis Clinical Trials Scientific Platform Session, Co-Chair
`American Academy of Neurology
`Rare Neuroimmunologic Disorders Symposium
`Director, Speaker, Dallas, Texas
`Rare Neuroimmunologic Disorders Symposium
`Director, Speaker, Dallas, Texas
`Acute Flaccid Myelitis Collaboration Meeting
`Organizer, Speaker, Dallas, Texas
`Acute Flaccid Myelitis Collaboration Meeting
`Consultant, CDC, Atlanta, GA
`Acute Flaccid Myelitis Collaboration Meeting
`Consultant, Speaker, CDC, Atlanta, GA
`Acute Flaccid Myelitis NIH Working Groups
`Consultant, Speaker
`Acute Flaccid Myelitis Collaboration Meeting
`Consultant, CDC, Atlanta, GA
`
`
`
`
`Students, Residents, Fellows Mentored
`
`
`2011-2012 Lindsay Horton Doris Duke Fellow
`2012-2014 Allen DeSena
`Jim Lubin TMA Fellow
`2010-2012 Kyle Noll
`Dissertation Committee
`2012-2014 Angela Canas
`Dissertation Committee
`2013-2015 Benjamin Arellano Dissertation Committee
`2014-2016 Angie Fayad
`Dissertation Committee
`2014-2016 Dilip Challa
`Dissertation Committee
`
`Research Mentor
`Clinical and Research Mentor
`
`
`PhD Candidate
`
`
`PhD Candidate
`
`
`PhD Candidate
`
`
`PhD Candidate
`
`
`PhD Candidate
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`June 27, 2018
`December, 2021
`January 14, 2022
`
`
`February, 2008
`
`April, 2010,
`
`September 24th –
`
`April 14, 2011,
`
`October 2012
`
`October 2015
`
`January, 2017
`
`September, 2017
`
`December 4, 2018
`
`April 16, 2019
`
`November, 2019
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 9 of 42
`
`

`

`9/22/2022
`
`National MS Society Fellow Clinical and Research Mentor
`2016-2018 Ram Narayan
`Jim Lubin TMA Fellow
`Clinical and Research Mentor
`2016-2018 Cynthia Wang
`Dissertation Committee
`
`
`PhD Candidate
`2016-2017 Alex Tan
`Dissertation Committee
`
`
`PhD Candidate
`2016-2017 Cole Hague
`National MS Society Fellow Clinical and Research Mentor
`2018-2020 Peter Sguigna
`Jim Lubin TMA Fellow
`Clinical and Research Mentor
`2018-2020 Kyle Blackburn
`National MS Society Fellow Clinical and Research Mentor
`2019-2020 Lauren Tardo
`2019-2021 Molly McGetrick Pediatric Critical Care Fellow
`
`Research Mentor
`2019-2022. Natasha Hanners Pediatric Infectious Disease Fellow
`K08 Committee
`2020-2021. Sarah Fredrich
`National MS Society Fellow Clinical and Research Mentor
`
`
`
`OTHER PROFESSIONAL ACTIVITIES OR POSITIONS
`
`
`National Multiple Sclerosis Society, Maryland Chapter, Professional Advisory Committee,
`Co- Chair, 2006-2008
`National Multiple Sclerosis Society, Maryland Chapter, Professional Education Committee,
`member, 2005-2006
`National Multiple Sclerosis Society, Maryland Chapter, Clinical Advisory
`Committee, member, 2005-2006
`Accelerated Cure Project, Scientific Advisory Board Member, 2005-2017
`Transverse Myelitis Association, Medical Advisory Board Member, 2005-present
`Guthy-Jackson Charitable Foundation for Neuromyelitis Optica, Medical and Scientific
`Advisory Board, 2008-2016
`NIH, Office of Rare Diseases, Biorepository and Bioregistry Committee, Co-Chair, 2010-
`2017
`National Multiple Sclerosis, 5 Star Region, Clinical Advisory Committee, Chair, 2009-2017
`International Pediatric Multiple Sclerosis Study Group, Member, 2012-present
`Rare Neuroimmunological Disorders Certification Board, Member, 2014-present
`CDC Acute Flaccid Myelitis Task Force, 2018-present
`University of Texas Health System Biorepository Consortium Committee Vice Chair;
`2018present
`PARADIGMS Study Steering Committee, Novartis, 2015-2020
`OLIKOS Study Steering Committee, Novartis, 2020-present
`Pediatric NeuroNEXT NIH Steering Committee, 2021-present
`
`
`MAJOR COMMUNITY SERVICE ORGANIZATIONS
`
`
`National Multiple Sclerosis Society, Maryland Chapter, Challenge Walk, Medical Director,
`2004-2006
`Fire Surgeon, Baltimore County, Lutherville Fire Company, 2004-2008
`
`
`
`PROFESSIONAL SOCIETIES
`
`
`2000-present American Academy of Neurology
`2009-present Texas Neurological Society
`2014-present American Neurological Association
`
`Fellow
`Member
`Fellow
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 10 of 42
`
`

`

`9/22/2022
`
`
`
`
`
`EDITORIAL RESPONSIBILITIES
`
`
`Editorial Board Member
`Neuroimmunology Reports (2019-present)
`
`
`Section Editor
`JAMA Neurology (2014-2016)
`
`
`Reviewer
`European Neurology
`Journal of Neurology, Neurosurgery and Psychiatry
`JAMA Neurology (formerly, Archives of Neurology)
`The Journal of Medicine
`Neurology
`Annals of Neurology
`Journal of Neuroimmunology
`Multiple Sclerosis Journal
`Brain
`Annals of Clinical and Translational Neurology
`Multiple Sclerosis Journal
`Multiple Sclerosis and Related Disorders
`
`
`RESEARCH REVIEW ACTIVITIES
`
`2007 Canadian Institute of Health Research Study Section
`2010 Department of Defense, Multiple Sclerosis Research, Grant Study Section
`2012 NIH Orphan and Rare Diseases Registry Study Section Reviewer
`2012 NINDS study section K, ad hoc reviewer
`2013 NINDS study section K, ad hoc reviewer
`2016 NINDS Zika Study Section reviewer
`2021
`French National Research Program
`2021 National Multiple Sclerosis Society Prodromal MS RFA Reviewer
`
`
`
`INVITED LECTURES
`
`
`“Multiple Sclerosis for the Internist”, Geriatrics Center, Johns Hopkins Bayview, Baltimore,
`MD October 2005 “Approach to Transverse Myelitis”, Apollo Hospital, Dehli, India
`
`December 2,
`2005 “Multiple Sclerosis Update For Internal Medicine”, Department of Internal Medicine
`Grand Rounds
`Peninsular Regional Hospital, Salisbury, MD
`“Clinico-pathologic Conference”, Department of Medicine Grand Rounds
`University of Maryland, Baltimore, MD
`
`April 18, 2006
`
`August 30, 2006
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 11 of 42
`
`

`

`December 6,
`
`October 6, 2010
`
`9/22/2022
`
`
`“Approach to the Patient with Acute Weakness”, Department of Medicine Grand Rounds
`Mercy Medical Center, Baltimore, MD
`January 24, 2007
`“Clinico-pathologic Conference”, Johns Hopkins School of Medicine
`March 6, 2007
`“Transverse Myelitis: Updates in Treatment and Research”, Department of Neurology Grand
`Rounds
`May 11, 2007
`Cooper University Hospital, Camden, NJ
`“Neurological complications of HIV infection in the post HAART era”, European
`Neurological Society; Rhodes, Greece
`June 16, 2007
`“Multiple Sclerosis: 2007 Clinical and Scientific Update”, Department of Medicine Grand
`Rounds
`Franklin Square Hospital, Baltimore, MD
`2007
`“Sphingosine 1 Receptors and Multiple Sclerosis”, Clinical Neurosciences Series,
`Johns Hopkins School of Medicine
`March 17, 2008
`“Diagnostic and therapeutic management of CNS infections in patients with abnormal T-cell
`or monocyte function”, European Neurological Society; Nice, France
`June 9, 2008
`“Transverse Myelitis: From Bedside to Bench and Back”, Multiple Sclerosis Center
`University of Texas Southwestern, Dallas, Texas;
`June 11, 2008
`“Pediatric Demyelinating Disease”, University of Texas Southwestern Medical Center,
`Department of Pediatrics Grand Rounds
`May 19, 2010
`“Multiple Sclerosis Update: A Revolution in Evolution” September 1, 2010
`Internal Medicine Grand Rounds, Presbyterian Hospital, Dallas, Texas
`“The Unknown in Biorepositories: The Dunning-Kruger Effect”
`Neurology Department Grand Rounds, UT Southwestern, Dallas, Texas
`Physical Medicine and Rehabilitation Grand Rounds, University of Texas Southwestern,
`Dallas, Texas
`January 7, 2011
`“Improving Outcomes in Transverse Myelitis”
`“Future Therapies and Clinical Trials in Neuromyelitis Optica”, Keynote Speaker, Sendai
`Japan NMO Research Conference
`July 16, 2011
`“Neuromyelitis Optica: A Model of its Kind for Translational Research” Dallas, Tx
`Neuroimmunology Seminar Series
`June 8, 2012
`“Neuromyelitis Optica: A Model of its Kind for Translational Research” Dallas, Tx
`Internal Medicine Grand Rounds, Presbyterian Hospital September 19, 2012
`“Transverse Myelitis for the Internist”
`Dallas, Tx Dallas
`Internists Club, UT Southwestern
`January 8, 2013
`“Diagnostic Approaches to Transverse Myelitis”, Meet the Professor Keynote,
`CMSC, Orlando, Fl
`May 29, 2013
`“Transverse Myelitis: New Revelations About an Old Disease”, Kennedy Krieger Institute
`Spinal Cord Program Symposium, Baltimore, MD
`June 16, 2014
`“Neuromyelitis Optica: Gaps in Knowledge”, Neuroimmunology and Neurocritical Care
`Conference, Washington, DC
`June 18, 2014
`“An Era of Transformation in Antibody Mediated CNS Diseases” Internal Medicine Grand
`Rounds, Presbyterian Hospital, Dallas Texas
` September 17,
`2014
`“Transverse Myelitis: Facing Fallacies and Understanding a Diseases”
`Washington University St. Louis, CNND Symposium
`“Multiple Sclerosis Update”, Albuquerque, NM VA
`“Multiple Sclerosis Update”, Dallas, Tx VA
`
`October 5, 2016
`December 5, 2016
`January 26, 2017
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 12 of 42
`
`

`

`February 3, 2017
`
`
`
`January 27, 2018
`February 2, 2018
`
`February 3, 2018
`
`May 2, 2018
`
`April 10, 2019
`June 22, 2019
`
`May 28,2020
`
`June 12, 2020
`
`9/22/2022
`
`
`“Translational Research in Demyelinating Diseases”
`PM&R Grand Rounds, UT Southwestern, Dallas, Texas
`“Complement and Neuromyelitis Optica, Apellis Complement Meeting
`Miami, Fl
`“Neuromyelitis Optica and Visual System”
`ACTRIMS/IMSVISUAL Meeting, San Diego, CA
`“What’s New in NMO and ADEM”
`Texas Neurological Society, Austin, Tx
`“Induction versus Escalation Therapy in Multiple Sclerosis”
`Neurology Grand Rounds, UT Southwestern, Dallas Texas
`“New Perspective on Myelitis: The Reemergence of Acute Flaccid Myelitis”
`Carol Krusen Conference, Dallas Texas
`February 22, 2019
`“Neuroimmunology of Behavioral Disorders”
`Keynote Lecture, Tourette Association of America, New York
`“Update on Stem Cell Therapies for Myelitis”
`Johns Hopkins TM Symposium, Baltimore, MD
`January 30, 2020
`“Acute Flaccid Myelitis”
`Keynote Speaker, British Pediatric Neurology Association, Belfast, Ireland
`“Acute Flaccid Myelitis”
`February 1, 2020
`Speaker, Birkdale Rehabilitation Conference, London, England
`“Emerging Therapies Across the Disease Spectrum”
`Speaker, Consortium of Multiple Sclerosis Centers, Annual Meeting
`“Acute Flaccid Myelitis: Putting the pieces together from
`admission to discharge”
`Johns Hopkins AFM Symposium
`“Safety of Approved NMOSD Therapeutics”
`Guthy-Jackson Charitable Foundation for NMO
`Clinical Pathologic Conference
`Methodist Dallas Hospital
`Update on Diagnosis and Treatment of NMOSD
`Texas Neurological Society
`Update of Pediatric CNS Autoimmune Disorders
`Texas Tech Department of Pediatric Grand Rounds
`Acute Neurological Care in Acute Flaccid Myelitis
`Steele Conference for Spinal Cord Dysfunction
`Immunological Considerations in Gene Therapy Trials
`Carol Krussen Conference
`Myelitis Update
`Baylor College of Medicine Pediatrics Grand Rounds
`
`
`
`RESEARCH SUPPORT Current Funding
`Greenberg (PI)
`Study of COVID-19 Omicron variant in an outpatient population
`Regeneron
`
`2021-2023
`Greenberg (PI)
`Study of COVID-19 Vaccine efficacy in immunosuppressed patient populations
`
`
`November 13, 2020
`
`April 15, 2021
`
`July 23, 2021
`
`December 3, 2021
`
`December 8, 2021
`
`February 25, 2022
`
`September 22, 2022
`
`2022-2023
`
`$1,161,000
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 13 of 42
`
`

`

`$2,125,000
`
`2021-2023
`
`$350,000
`
`$500,000
`
`2020-2022
`$240,000
`10% Effort
`
`9/22/2022
`
`
`Regeneron
`
`Greenberg (PI)
`A phase 1 study of ANK700 in patients with multiple sclerosis
`Anokion
`
`2021-2030
`Greenberg (PI)
`A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous
`Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis,
`BEAT-MS
`NIH/ITN
`
`2020-2024
`Greenberg (PI and IND Sponsor)
`Phase I Intrathecal Lumbar Administration of AAV9/CLN7 for Treatment of CLN7 Disease
`UTSW/Children’s Health Funding
`
`
`
`
`
`$1,300,000
`
`
`Greenberg (PI)
`AFM Surveillance Study
`CDC
`
`2018-2023
`Greenberg (co-I)
`Contribution of plasmablasts in the conversion of transverse myelitis to multiple sclerosis
`(Monson PI)
`
`
`
`
`
`
`
`
`$2,816,935
`NIH R0101NS102417-01A1
`
`
`
`
`
`3% Effort
`
`
`Greenberg (PI)
`REPAIR MS
`Phase 1/2 Trial of CLENE Nanoparticle in MS
`
`Greenberg (PI)
`CONQUER
`TM Stem Cell Phase 1 Study
`
`
`
`
`Past Funding
`
`Greenberg (PI)
`National Multiple Sclerosis Society
`Institutional Clinician Training Award
`
`Greenberg (co-I)
`REPAIR PD
`Phase 1/2 Trial of CLENE Nanoparticle in PD
`
`Greenberg (PI)
`PCORI
`
`2017-2024
`$1,500,000
`20% Effort
`
`2019-2023
`$450,000
`7% Effort
`
`2016-2021
`$584,000
`2% Effort
`
`2019-2021
`$400,000
`5% Effort
`
`2013-2019
`$1,500,000
`
`Petitioner TWi Pharms., Inc.
`EX1006, Page 14 of 42
`
`

`

`
`
`9/22/2022
`
`
`CAPTURE Study
`
`Greenberg (PI)
`Guthy Jackson Charitable Foundation
`NMO Biorepository
`
`Greenberg (PI)
`Medimmune
`
`Medi551